Recombinant multi-species ST6GAL1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ST6GAL1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of glycosyltransferase family 29. The encoded protein is a type II membrane protein that catalyzes the transfer of sialic acid from CMP-sialic acid to galactose-containing substrates. The protein, which is normally found in the Golgi but can be proteolytically processed to a soluble form, is involved in the generation of the cell-surface carbohydrate determinants and differentiation antigens HB-6, CD75, and CD76. This gene has been incorrectly referred to as CD75. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
The Alternative Names of target: 6-ST 1,6-sialyltransferase 1,Alpha 2,B-cell antigen CD75,Beta-galactoside alpha-2,CDw75,CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,SIAT1,ST6GAL1,ST6Gal I (ST6GalI),ST6GalI,ST6N,Sialyltransferase 1,Siat1,St6Gal-I,St6gal,St6gal1,St6galI

Target products collectionGo to ST6GAL1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1325-Ag-1/ GM-Tg-hg-SE1325-Ag-2 Human ST6GAL1 protein Human
GM-Tg-rg-SE1325-Ag-1/ GM-Tg-rg-SE1325-Ag-2 Rat ST6GAL1 protein Rat
GM-Tg-mg-SE1325-Ag-1/ GM-Tg-mg-SE1325-Ag-2 Mouse ST6GAL1 protein Mouse
GM-Tg-cynog-SE1325-Ag-1/ GM-Tg-cynog-SE1325-Ag-2 Cynomolgus/Rhesus macaque ST6GAL1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1325-Ag-1/ GM-Tg-felg-SE1325-Ag-2 Feline ST6GAL1 protein Feline
GM-Tg-cang-SE1325-Ag-1/ GM-Tg-cang-SE1325-Ag-2 Canine ST6GAL1 protein Canine
GM-Tg-bovg-SE1325-Ag-1/ GM-Tg-bovg-SE1325-Ag-2 Bovine ST6GAL1 protein Bovine
GM-Tg-equg-SE1325-Ag-1/ GM-Tg-equg-SE1325-Ag-2 Equine ST6GAL1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1325-Ag-1/ GM-Tg-hg-SE1325-Ag-2; GM-Tg-rg-SE1325-Ag-1/ GM-Tg-rg-SE1325-Ag-2;
GM-Tg-mg-SE1325-Ag-1/ GM-Tg-mg-SE1325-Ag-2; GM-Tg-cynog-SE1325-Ag-1/ GM-Tg-cynog-SE1325-Ag-2;
GM-Tg-felg-SE1325-Ag-1/ GM-Tg-felg-SE1325-Ag-2; GM-Tg-cang-SE1325-Ag-1/ GM-Tg-cang-SE1325-Ag-2;
GM-Tg-bovg-SE1325-Ag-1/ GM-Tg-bovg-SE1325-Ag-2; GM-Tg-equg-SE1325-Ag-1/ GM-Tg-equg-SE1325-Ag-2
Products Name ST6GAL1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ST6GAL1
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ST6GAL1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.